Skip to main content

Table 1 Baseline characteristics of 133 HIV-positive subjects from the SHCS and 5328 HIV-negative subjects from the AMIS registry at the time of their first myocardial infarction

From: Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study

  SHCS AMIS registry  
  HIV-positive subjects HIV-negative subjects  
  Total   Total   P_values a
Age, year 133 51 (46–57) 5328 64 (55–74) <0.0001
Men 133 113 (85.0) 5328 3845 (72.2) 0.001
Weight (kg) 121 71 (63–71) 5167 78 (69–88) <0.0001
Height (cm) 133 174 (169–178) 4803 171 (165–176) 0.0003
Body Mass Index (kg/m 2 ) 121 23. (21.6–26.1) 4801 26.5 (24.2–29.4) <0.0001
Blood pressure      
Systolic (mmHg) 119 132 (120–149) 5273 140 (120–160) 0.0034
Diastolic (mmHg) 119 75 (83–90) 5270 81 (71–94) 0.9015
Other cardiovascular risk factors      
Smoking history 132   5094   <0.0001
- Active smokers   77 (58.3)   2009 (39.4)  
- Former smokers   23 (17.5)   1311 (25.7)  
- Non smokers   32 (24.2)   1774 (34.8)  
Family history of CAD b 133 18 (13.5) 4717 1571 (33.3) <0.0001
Hypertension 133 32 (24.1) 5323 3231 (60.7) <0.0001
Diabetes mellitus 133 18 (13.5) 4734 739 (15.6) 0.569
Biological parameters      
Glycemia (mmol/l) 116 5.3 (4.7–6.0) 4920 7.1 (6.1–8.8) <0.0001
Total cholesterol (mmol/l) 120 5.4 (4.5–6.3) 4078 5.4 (4.6–6.2) 0.952
HDL cholesterol (mmol/l) 120 1.1 (0.9–1.3) 3720 1.2 (1.0–1.5) 0.005
Serum creatinine (umol/l) 121 80 (69–93) 5158 81 (69–94) 0.779
Discharge AMI diagnosis 110   5328   0.025
STEMI   53 (48.2)   3135 (58.8)  
NSTEMI   57 (51.8)   2193 (41.2)  
Current cardiovascular treatments      
Platelets inhibitor recipients 133 120 (90.2) 5326 5169 (97.0) <0.0001
Antihypertensive drugs 133 107 (80.5) 5327 4735 (88.9) 0.002
Lipid lowering drugs 133 115 (86.5) 5325 5028 (94.4) <0.0001
  1. Data are no. (%) of subjects or median (interquartile range).
  2. aWilcoxon rank-sum test for quantitative variables and chi square test for qualitative variable bCAD: coronary artery disease.